Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-01 5:00 pm Purchase | 2022-05-27 | 13D | Kymera Therapeutics, Inc. KYMR | BIOTECHNOLOGY VALUE FUND L P | 4,138,758 8.000% | 552,100 (+15.39%) | Filing History |
| 2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group, LLC | 2,587,730 5.000% | -132,759 (-4.88%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | T. Rowe Price Associates, Inc. | 3,550,528 6.900% | 3,550,528 (New Position) | Filing History |
| 2022-02-11 5:09 pm Sale | 2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Atlas Venture Fund X, L.P. | 5,763,012 11.200% | -2,185,970 (-27.50%) | Filing History |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | The Vanguard Group | 2,957,174 5.750% | 2,957,174 (New Position) | Filing History |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | Kymera Therapeutics, Inc. KYMR | FMR LLC | 2,347,527 4.568% | -94,533 (-3.87%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | BlackRock Inc. BLK | 3,397,540 6.600% | 3,397,540 (New Position) | Filing History |
| 2022-02-04 09:27 am Purchase | 2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Wellington Management Group LLP | 2,694,814 5.240% | 2,694,814 (New Position) | Filing History |
| 2022-01-31 5:07 pm Purchase | 2022-01-27 | 13D | Kymera Therapeutics, Inc. KYMR | BIOTECHNOLOGY VALUE FUND L P | 3,586,658 7.000% | 955,996 (+36.34%) | Filing History |
| 2021-02-16 5:27 pm Purchase | 2020-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Atlas Venture Fund X, L.P. | 7,948,982 17.900% | 7,948,982 (New Position) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Redmile Group, LLC | 2,720,489 6.100% | 2,720,489 (New Position) | Filing History |
| 2021-02-08 10:27 am Purchase | 2021-02-05 | 13G | Kymera Therapeutics, Inc. KYMR | FMR LLC | 2,442,060 5.492% | 2,442,060 (New Position) | Filing History |